Adenocarcinoma, Clear Cell
"Adenocarcinoma, Clear Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenocarcinoma characterized by the presence of varying combinations of clear and hobnail-shaped tumor cells. There are three predominant patterns described as tubulocystic, solid, and papillary. These tumors, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. (From Holland et al., Cancer Medicine, 3d ed)
| Descriptor ID |
D018262
|
| MeSH Number(s) |
C04.557.470.200.025.045
|
| Concept/Terms |
Adenocarcinoma, Clear Cell- Adenocarcinoma, Clear Cell
- Adenocarcinomas, Clear Cell
- Clear Cell Adenocarcinoma
- Clear Cell Adenocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma, Clear Cell".
Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma, Clear Cell".
This graph shows the total number of publications written about "Adenocarcinoma, Clear Cell" by people in this website by year, and whether "Adenocarcinoma, Clear Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 0 | 1 | 1 |
| 1998 | 1 | 2 | 3 |
| 2000 | 3 | 0 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 0 | 3 |
| 2003 | 0 | 4 | 4 |
| 2004 | 5 | 3 | 8 |
| 2005 | 3 | 5 | 8 |
| 2006 | 2 | 5 | 7 |
| 2007 | 3 | 3 | 6 |
| 2008 | 2 | 4 | 6 |
| 2009 | 3 | 1 | 4 |
| 2010 | 1 | 1 | 2 |
| 2011 | 4 | 1 | 5 |
| 2012 | 2 | 3 | 5 |
| 2013 | 1 | 0 | 1 |
| 2014 | 3 | 1 | 4 |
| 2015 | 2 | 3 | 5 |
| 2016 | 2 | 2 | 4 |
| 2017 | 4 | 1 | 5 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenocarcinoma, Clear Cell" by people in Profiles.
-
Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 Expression. JCO Precis Oncol. 2024 Jun; 8:e2300686.
-
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016. Gynecol Oncol. 2024 07; 186:61-68.
-
Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis. Front Endocrinol (Lausanne). 2023; 14:1162786.
-
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 02; 21(2):181-209.
-
Clear cell carcinoma of the endometrium. Gynecol Oncol. 2022 03; 164(3):658-666.
-
Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics. Am J Obstet Gynecol. 2021 10; 225(4):367.e1-367.e39.
-
Rapidly Enlarging Hidradenoma of the Eyelid. Ophthalmic Plast Reconstr Surg. 2021 May-Jun 01; 37(3S):S149-S151.
-
Pten and Dicer1 loss in the mouse uterus causes poorly differentiated endometrial adenocarcinoma. Oncogene. 2020 10; 39(40):6286-6299.
-
Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience. Gynecol Oncol. 2019 08; 154(2):328-332.
-
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer. Cancer Prev Res (Phila). 2019 06; 12(6):391-400.